Final Results PR Newswire

31 July 2020


(“Ananda” or the “Company”)

Final Results

The Directors of Ananda are pleased to present the audited financial statements of Ananda Developments Plc for the year ended 31 January 2020.

Business Review, Development and Performance

The Company was admitted to trading on the NEX Exchange Growth Market on 4 July 2018 as an investment vehicle to invest in the developing market for medicinal or therapeutic cannabis. Initially, the Company’s strategy was focused specifically on companies, projects or products in Israel, Canada and the Netherlands, although this strategy was broadened in September 2018 to permit investment in any jurisdiction which has well established laws in relation to medicinal cannabis.

Since the Company was listed in 2018, the Directors have pursued their primary objective of creating long term value for Shareholders through the acquisition of strategic stakes in companies in the medicinal cannabis and wellness CBD sectors which the Directors believe have potential for substantial growth.  The current investments are:

•             a shareholding of 0.90% in iCAN Israel-Cannabis Limited, an international cannabis conference platform and cannabis company incubator and advisor. In the year under review, iCAN has expanded its conference platform and increased the number of companies in its incubator group.  Since the end of the reporting period, iCAN has transitioned to an online offering to maintain revenue streams during the COVID-19 pandemic.   Also since the end of the period, Ananda has converted its convertible debt into additional equity in iCAN.

•             15% interest in Liberty Herbal Technologies Limited (“LHT”), the 100 per cent owner and developer of hapac®, ready to use sachets of pre-ground dried herbs for portable vaporisers.  During the period under review, LHT continued to sell its hapac devices and sachets in Italy.  It has also commenced a range of discussions regarding potential collaborations to expand the footprint of the company.

•             50% (via 100% owned Tiamat Agriculture and 50% owned DJT Group Limited) interest in DJT Plants Limited, which is applying for a licence to grow medicinal cannabis in Lincolnshire, first for research and ultimately for commercial purposes.  During the period under review, the Home Office, which grants the licence, has been in communication and the application is progressing.

The Company is very much in its early stages with its investments not yet generating any revenue. The Company has had no revenue for the year, apart from £9,056 of interest, and incurred a loss of £374,460.

Statement of Comprehensive Income

Year Ended 31 January 2020

                                                  19 Jan 2018 to 31 Jan 2019
                                      31 Jan 2020

                                                £                          £

Administrative expenses                 (375,224)                  (368,299)

Interest receivable                         9,056                      4,061

Loss from operations                    (366,168)                  (364,238)

Taxation                                        -                          -

Other Comprehensive Income

Foreign Exchange Translation Loss         (8,292)                          -

Total comprehensive loss for the year   (374,460)                  (364,238)


Earnings per share

Basic and diluted earnings per share (pence) (0.10p) (0.11p)

There was no other comprehensive income in the period.

Statement of Financial Position

Year Ended 31 January 2020

                                                  19 Jan 2018 to 31 Jan 2019
                                      31 Jan 2020

                                                £                          £

Non-Current assets

Investments                             1,287,762                    460,000

                                        1,287,762                    460,000

Current assets

Loan Notes                                 75,878                    159,185

Trade and other receivables                22,574                     18,191

Cash at bank and in hand                   33,925                    141,254

Total current assets                      132,377                    318,630

Trade and other payables                  191,742                     17,528

Net current assets                       (59,365)                    301,102

Total assets less current liabilities   1,228,397                    761,102

Capital and reserves

Share capital                             836,111                    658,333

Share premium                             689,229                    467,007

Share options reserve                     441,755                          -

Retained earnings                       (738,698)                  (364,238)

Total equity and liabilities            1,228,397                    761,102

The financial statements were approved and authorised for issue by the Board and were signed on its behalf by:

Melissa Sturgess


The auditor’s opinion in respect of the Company’s accounts for the year ended 31 January 2020 is qualified as follows:

“Basis for qualified opinion

The company’s Statement of Financial Position as at 31 January 2020 reports a balance of £33,925 relating to cash at bank and in hand.  The underlying bank account in which this amount is held does not relate to the company. As the company does not hold legal title or ownership of the funds included within the underlying bank account, the requirements of the financial reporting framework to recognise the asset in the Statement of Financial Position have not been met.   Accordingly, the value of cash at bank and in hand as at 31 January 2020 should be £0.”


The Directors of the Company accept responsibility for the contents of this announcement.

ANANDA DEVELOPMENTS PLC         +44 (0)7717 573 235
Chief Executive Officer
Melissa Sturgess

Investor Relations
Jeremy Sturgess-Smith

PETERHOUSE CAPITAL LIMTED       +44 (0)20 7469 0930
Corporate Finance
Mark Anwyl
Allie Feuerlein

Corporate Broking
Lucy Williams
Duncan Vasey

CELICOURT COMMUNICATIONS        +44 (0)20 7520 9266
Mark Antelme
Ollie Mills

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.